BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
News | 05. 21. 2013
Scott will provide his perspective on the investment outlook for early stage companies on a panel at the Bloom Burton & Co Technology Transfer Conference May 21 in Toronto.
